People · Operator
Named in public records as an officer, director or promoter · active 2011–2015 · Other Health Care, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| InfoBionic, Inc. | — | Other Health Care | Series C | $103.8M | $573.7M | 2012 |
| Annovation BioPharma, Inc. | — | Pharmaceuticals | Series A | $10.4M | $247.8M | 2011 |
Carl Berke at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Carl Berke on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jean-Francois Formela | 1 | 17 |
| David Grayzel | 1 | 6 |
| Al Wiegman | 1 | 5 |
| Caleb Winder | 1 | 5 |
| ANKIT MAHADEVIA | 1 | 4 |
| NANCY BRIEFS | 1 | 4 |
| Steven Wasserman | 1 | 3 |
| Peter Van Der Sluis | 1 | 3 |
| Hamid Tabatabaie | 1 | 3 |
| Brian Sisko | 1 | 3 |
| Adrian Steckel | 1 | 2 |
| Michael Fahey | 1 | 2 |
| Ravi Kuppuraj | 1 | 2 |
| Shirley Gee | 1 | 2 |
| Serban Georgescu | 1 | 1 |
| Jason Campagna | 1 | 1 |
| Kiran Rao | 1 | 1 |
| Philip Leone | 1 | 1 |
| Nicholas Barker | 1 | 1 |
| Peter Noseworthy | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.